🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We'd like to congratulate Alan Ho on his new role as Chief of the Head and Neck Oncology Service within the Division of Solid Tumor Oncology in the Department of Medicine at MSK. Learn more about Dr. Ho ➡️ bit.ly/3ZI1qVB #ESMO24

A team of doctors & researchers at MSK have identified a new, rare type of small cell #lungcancer that primarily affects younger people who have never smoked. Natasha Rekhtman MD PhD & Charlie Rudin published a paper in Cancer Discovery w/ their analysis. Learn more: bit.ly/3XqYKZG

FDA approves first-line pembrolizumab plus platinum + pemetrexed (up to 6 cycles) for advanced malignant pleural #mesothelioma. Based on KEYNOTE-483 (IND 227) that showed adding pembrolizumab improved OS (HR 0.79). fda.gov/drugs/resource…

Important work from Natasha Rekhtman MD PhD Charlie Rudin and colleagues Memorial Sloan Kettering Cancer Center defining a novel subtype of atypical small cell lung cancer in never/light smokers, associated with chromothripsis and lacking RB1/TP53 inactivation. #LCSM aacrjournals.org/cancerdiscover…

Characterization of NVL-655 in ALK+ lung cancer now out in Cancer Discovery from JessicaJLinMD Alexander Drilon MD and colleagues. ALK Positive ALK+ International #LCSM aacrjournals.org/cancerdiscover…

🔔#WCLC24 9/25/24 LINK BELOW UPDATES ON: Harmoni 2  Bay/Zongertinib for HER2 CM77T / 816 comparison  Neocoast Tropion lung 01 Mariposa/Mariposa2 Saci for small cell We will break the data ⬇️to digestible bites and highlight what we feel is actually practice changing !

#SaveTheDate for LCRF's 2024 Scientific Symposium: Monday, Nov. 4, 3-6pm ET. Our experts will lead a discussion on Lung Cancer: Addressing Unmet Needs. Registration is open for this virtual event: LCRF.org/symposium #LungCancer #LCAM

Excited for this year's Symposium! Join O'Donnell Lab Brendon Stiles colleen ziegler Mark Awad Joseph Greer, PhD Lauren Averett Byers, MD Hossein Borghaei, DO & Don Nguyen, PhDBSc for a lively discussion #lcsm

Important piece on supporting our international medical graduates (IMGs) in hematology/oncology. The IMGs I've had the pleasure of working with over the years have been among the best mentors, mentees, teachers, physicians, and researchers. ascopubs.org/doi/10.1200/OP…

👏 Congratulations to Dr. Deb Schrag, Chair of the MSK Department of Medicine, and Dr. Lorenz, Director of the Center for Stem Cell Biology at MSK, who were elected to the National Academy of Medicine, one of the highest honors bestowed upon scientists worldwide. Learn more: bit.ly/4fvwkoP

Register now for LCRF's 2024 Scientific Symposium: Monday, Nov. 4, 3-6pm ET. Our experts will lead a live, virtual discussion on Lung Cancer: Addressing Unmet Needs. Sign up at LCRF.org/symposium. #LungCancer #LCAM

Joining us are speakers and panelists Mark Awad Brendon Stiles colleen ziegler Lauren Averett Byers, MD Hossein Borghaei, DO, Joseph Greer, PhD; Don Nguyen, PhD, BSc; and Kathryn O'Donnell, PhD; with chat moderator Isabel Preeshagul. Excited to hear from these experts!

‼️📣 Calling ALL patients with Lung Cancer📣 ‼️ Your candid opinions will help guide the future! I am conducting with Ishwaria Subbiah, MD MS FASCO Devika Das, MD, MSHQS a de- identified survey addressing barriers to clinical trial accrual. SURVEY LINK and Preamble BELOW 👇🏽 surveymonkey.com/r/37P79WB

Now online in Cancer Discovery: Antitumor Activity of Vebreltinib & Characterization of Clinicogenomic Features in Tumors with MET Rearrangements - by Seshiru Nakazawa, Federica Pecci, Igor Odintsov, Pasi Janne, Mark Awad, et al. doi.org/10.1158/2159-8… Dana-Farber Memorial Sloan Kettering Cancer Center

Congratulations to the MSK-IMPACT team at MSK for receiving the American Association for Cancer Research (AACR) Team Science Award. The team, led by Michael Berger, David B. Solit, MD, and Marc Ladanyi, is recognized for its pivotal advances in clinical genomic sequencing that have transformed

Join MSK thoracic medical oncologist Dr. Kathryn Arbour (Kathryn C. Arbour) for a plenary session titled “Preliminary safety and antitumor activity of zoldonrasib (RMC-9805), an oral, RAS(ON) G12D-selective, tri-complex inhibitor in patients with KRAS G12D non-small cell lung cancer

In her plenary session at #AACR25, Andrea Cercek shared that PD-1 #immunotherapy can eliminate the need for surgery in patients with early-stage, DNA mismatch repair-deficient solid cancers. Learn more: bit.ly/3GvgqP2 AACR

Ph1 trial of zoldonrasib (RMC-9805), an oral KRAS G12D inhibitor in pts w/ #NSCLC showed ORR of 61%. Side effects primarily gastro-intestinal. Great to see new options for this pt group. Kathryn C. Arbour Memorial Sloan Kettering Cancer Center #AACR25 KRASKickers